Proven immune markers even now protect their relevance for medical decision-generating in breast most cancers cure with even prolonged meanings. Estrogen receptor (ER) amount must not only be classified in constructive or adverse. Very low ER degrees ?ten% of labeled cells has to be managed otherwise (LoE 1a/A/AGO++). Tumors with low ER ranges tend